Literature DB >> 10843310

One thousand health-related quality-of-life estimates.

T O Tengs1, A Wallace.   

Abstract

OBJECTIVE: Analysts performing cost-effectiveness analyses often do not have the resources to gather original quality-of-life (QOL) weights. Furthermore, variability in QOL for the same health state hampers the comparability of cost-effectiveness analyses. For these reasons, opinion leaders such as the Panel on Cost-Effectiveness in Health and Medicine have called for a national repository of QOL weights. Some authors have responded to the call by performing large primary studies of QOL. We take a different approach, amassing existing data with the hope that it will be combined responsibly in meta-analytic fashion. Toward the goal of developing a national repository of QOL weights to aid cost-effectiveness analysts, 1,000 health-related QOL estimates were gathered from publicly available source documents.
METHODS: To identify documents, we searched databases and reviewed the bibliographies of articles, books, and government reports. From each document, we extracted information on the health state, QOL weight, assessment method, respondents, and upper and lower bounds of the QOL scale. Detailed guidelines were followed to ensure consistency in data extraction.
RESULTS: We identified 154 documents yielding 1,000 original QOL weights. There was considerable variation in the weights assessed by different authors for the same health state. Methods also varied: 51% of authors used direct elicitation (standard gamble, time tradeoff, or rating scale), 32% estimated QOL based on their own expertise or that of others, and 17% used health status instruments.
CONCLUSIONS: This comprehensive review of QOL data should lead to more consistent use of QOL weights and thus more comparable cost-effectiveness analyses.

Mesh:

Year:  2000        PMID: 10843310     DOI: 10.1097/00005650-200006000-00004

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  185 in total

1.  Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

Authors:  B George; A Harris; A Mitchell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to prevent surgical site infection.

Authors:  Rachel R Bailey; Dianna R Stuckey; Bryan A Norman; Andrew P Duggan; Kristina M Bacon; Diana L Connor; Ingi Lee; Robert R Muder; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

4.  Understanding differences between self-ratings and population ratings for health in the EuroQOL.

Authors:  Ralph P Insinga; Dennis G Fryback
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

5.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results.

Authors:  Dong Soo Lee; Myoung Jin Jang; Gi Jeong Cheon; June-Key Chung; Myung Chul Lee
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

7.  Integrating health profile with survival for quality of life assessment.

Authors:  Jing-Shiang Hwang; Jung-Der Wang
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

8.  The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.

Authors:  T Younis; D Rayson; C Skedgel
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

9.  The costs and benefits of automatic estimated glomerular filtration rate reporting.

Authors:  Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

10.  Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Authors:  Michelle H Leppert; Sharon N Poisson; John D Carroll; David E Thaler; Chong H Kim; Karen D Orjuela; P Michael Ho; James F Burke; Jonathan D Campbell
Journal:  Stroke       Date:  2018-05-02       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.